Ed Miseta - Chief Editor, Clinical Leader & Outsourced Pharma

Ed Miseta

Ed Miseta



Ed Miseta is chief editor for the website Clinical Leader, executive editor for Life Science Leader magazine, conference chair for Clinical Leader Forum, and host of Clinical Leader Live. Ed studied Business Economics at The Pennsylvania State University and also holds a Master’s degree in Business Administration. Ed has been a writer for more than 12 years and has been covering clinical research since January 2013. Ed spent 10 years in banking and investments and also taught economics at Penn State for 8 years. In his current position, Ed interviews clinical executives from pharmaceutical and biotech companies and shares their insights with readers. His primary focus is on best practices, challenges faced and overcome, clinical trends, partnering, and implementing new technologies. He has also moderated numerous speaker panels at industry conferences and trade shows.

ED'S WORK

IST Clinical Trials -Martin Lehr_450x300
A Small Biopharma That Doesn’t Use CROs
When it comes to conducting clinical trials, most emerging companies choose to access external resources through partnering with CROs. That is what makes Martin Lehr, CEO of Context Therapeutics different. He prefers to bypass CROs and take part in Investigator-Sponsored Trials (ISTs).  Continue Reading..
Patient Diversity (002)
Patient Diversity Starts With Community Connections
When it comes to clinical trials, the pharmaceutical industry still has a patient diversity problem. The face of patients in clinical trials is not representative of the face of America or the individuals projected to be most in need of the medications being developed.  Continue Reading..
Clinical Trials_Wendi_Lau_450x300
Technology Advancements Spur Adoption Of Virtual Trials
Virtual trials have been around for years, so why are they still met with skepticism? Clinical trial executives from Janssen and Astellas weigh in on this hot topic for 2020.  Continue Reading..
Virtual Trials
What Exactly Is A Virtual Clinical Trial?
Oracle Health Sciences and the CNS Summit have released a research report on the use of virtual components (patient-facing technologies) in clinical trials. The findings are the result of focus group interviews and supplementary research with key stakeholders involved with clinical trials.  Continue Reading..
cell therapy (002)
Former Novartis CEO: Cell And Gene Therapies Will Drive Innovation
Joe Jimenez joined Novartis as division head of Consumer Health. A few months later, he was asked to run the pharmaceutical division. Shortly after his promotion to CEO, Novartis was the first company to pursue a CAR T therapy. Today, Jimenez marvels at the innovation taking place in the industry, and believes cell and gene therapies will drive future development.   Continue Reading..
Dana Dornsife Lazarex_450x300
Patient Diversity Starts With Community Connections
When it comes to clinical trials, the pharmaceutical industry still has a patient diversity problem. The face of patients in clinical trials is not representative of the face of America.  Continue Reading..
Merck_Shaughnessy
Success In HIV Treatments Creates Additional Challenges For Drug Developers
HIV drug developers have a whole new set of challenges, including making the regimens simpler better tolerated. In addition, since today’s patients can access these medicines through pharmacies, they no longer have the incentive to take part in clinical studies.  Continue Reading..
Regeneron_Bari_450x300
Regeneron Manages Clinical Costs In A Fast-Growing Organization
Bari Kowal, VP and head of global clinical operations at Regeneron, says sponsors and CROs must partner to make clinical trial execution more efficient and cost-effective.  Continue Reading..
01_FromThe CRO 0517_450by300
CRO Leadership Awards Move To Primetime
If you are looking for a CRO to help take your molecule through clinical trials and the process of gaining regulatory approval, who do you turn to? It’ not like there is an Angie’s List for CROs.  Continue Reading..
Rob_Scott_450x300
AbbVie Goes All-In On Wearables And Digital Technologies
Three years ago, AbbVie decided to stop talking about using digital technologies in clinical trials and start actually using them. The company then began deploying wearables in three clinical trials.  Continue Reading..